HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Axel Ullrich Selected Research

Axel Ullrich Research Topics

Disease

73Neoplasms (Cancer)
04/2019 - 01/2002
20Breast Neoplasms (Breast Cancer)
08/2016 - 03/2002
10Carcinoma (Carcinomatosis)
04/2013 - 02/2002
8Neoplasm Metastasis (Metastasis)
03/2014 - 09/2005
7Carcinogenesis
12/2011 - 06/2002
5Glioma (Gliomas)
03/2016 - 02/2005
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2017 - 05/2002
4Glioblastoma (Glioblastoma Multiforme)
03/2016 - 03/2004
4Hepatocellular Carcinoma (Hepatoma)
10/2014 - 07/2002
4Melanoma (Melanoma, Malignant)
07/2012 - 08/2008
3Insulin Resistance
01/2019 - 09/2011
3Obesity
01/2018 - 09/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2015 - 11/2002
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2003 - 03/2002
2Type 2 Diabetes Mellitus (MODY)
05/2017 - 01/2016
2Lymphoma (Lymphomas)
03/2014 - 03/2003
2Kidney Neoplasms (Kidney Cancer)
12/2013 - 08/2010
2Ovarian Neoplasms (Ovarian Cancer)
10/2012 - 08/2008
2Disease Progression
07/2012 - 06/2006
2Inflammation (Inflammations)
09/2011 - 02/2004
2Brain Neoplasms (Brain Tumor)
04/2006 - 02/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2004 - 11/2003
2Infections
10/2002 - 08/2002
1Lung Neoplasms (Lung Cancer)
05/2017
1Insulinoma
01/2017

Drug/Important Bio-Agent (IBA)

15ErbB Receptors (EGF Receptor)IBA
04/2014 - 06/2002
13Phosphotransferases (Kinase)IBA
07/2018 - 04/2003
13LigandsIBA
10/2017 - 11/2002
10Proteins (Proteins, Gene)FDA Link
01/2014 - 08/2001
9Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2016 - 02/2005
9Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2014 - 11/2002
8Pharmaceutical PreparationsIBA
05/2017 - 01/2002
8Metalloproteases (Metalloproteinases)IBA
02/2009 - 11/2002
7Epidermal Growth Factor (EGF)IBA
08/2010 - 12/2002
6Type 4 Fibroblast Growth Factor ReceptorIBA
01/2019 - 08/2006
6Tyrosine Kinase InhibitorsIBA
01/2017 - 03/2002
6Small Interfering RNA (siRNA)IBA
03/2015 - 10/2005
5Biological ProductsIBA
05/2017 - 11/2003
5tyrosine receptor (receptor, tyrosine)IBA
08/2016 - 01/2004
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 06/2002
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012 - 06/2004
5Tyrosine (L-Tyrosine)FDA Link
10/2006 - 11/2002
4Axl Receptor Tyrosine KinaseIBA
10/2017 - 04/2006
4Messenger RNA (mRNA)IBA
01/2014 - 11/2003
4Imatinib Mesylate (Gleevec)FDA Link
07/2012 - 03/2002
4EnzymesIBA
03/2008 - 08/2001
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2006 - 01/2004
3Sunitinib (Sutent)FDA Link
01/2017 - 03/2009
3Serine (L-Serine)FDA Link
01/2016 - 08/2005
3Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
04/2013 - 06/2004
3Trastuzumab (Herceptin)FDA Link
12/2012 - 03/2002
3Hormones (Hormone)IBA
12/2011 - 09/2005
3DisintegrinsIBA
02/2009 - 05/2003
3Complementary DNA (cDNA)IBA
02/2009 - 02/2002
3Neuregulin-1 (Neuregulin 1)IBA
08/2008 - 02/2005
3Protein Kinases (Protein Kinase)IBA
03/2008 - 08/2001
3orantinib (SU6668)IBA
08/2005 - 02/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2004 - 01/2002
3lysophosphatidic acidIBA
11/2004 - 11/2002
2LipidsIBA
01/2019 - 04/2006
2N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA
10/2017 - 03/2016
2salinomycinIBA
08/2016 - 12/2012
2AmphiregulinIBA
03/2015 - 05/2003
2Sorafenib (BAY 43-9006)FDA Link
10/2014 - 07/2012
2Protein Kinase InhibitorsIBA
07/2012 - 08/2005
2Monoclonal AntibodiesIBA
02/2012 - 08/2008
2Biomarkers (Surrogate Marker)IBA
09/2011 - 05/2008
2Oncogene Proteins (Oncogene Protein)IBA
08/2010 - 11/2002
2Gefitinib (Iressa)FDA Link
08/2010 - 05/2006
2Growth Factor ReceptorsIBA
01/2010 - 04/2006
2NucleotidesIBA
01/2010 - 04/2003
2DNA (Deoxyribonucleic Acid)IBA
02/2009 - 11/2002
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2009 - 08/2004
2ElementsIBA
03/2008 - 01/2008
2ParaffinIBA
01/2008 - 08/2004
2Protein Tyrosine PhosphatasesIBA
10/2006 - 03/2004
2Codon (Codons)IBA
08/2006 - 06/2006
2Arginine (L-Arginine)FDA Link
06/2006 - 02/2002
2Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2006 - 02/2002
2CarcinogensIBA
05/2006 - 11/2002
2Angiopoietin-1IBA
02/2006 - 06/2002
2Peptide Hydrolases (Proteases)FDA Link
10/2005 - 06/2004
2Matrix Metalloproteinases (MMPs)IBA
03/2005 - 12/2002
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2005 - 02/2004
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2005 - 02/2004
2ADAM17 ProteinIBA
11/2004 - 03/2004
2Indicators and Reagents (Reagents)IBA
02/2004 - 05/2002
2Oxygen (Dioxygen)IBA
11/2003 - 06/2002
2Carbachol (Carbastat)FDA Link
05/2003 - 11/2002
1CateninsIBA
04/2019
1Bile Acids and Salts (Bile Acids)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Amino AcidsFDA Link
01/2019
1G-Protein-Coupled Receptor Kinase 5IBA
01/2018
1Metformin (Glucophage)FDA LinkGeneric
05/2017
1Selective Estrogen Receptor Modulators (SERM)IBA
08/2016
1TamoxifenFDA LinkGeneric
08/2016
1Phenobarbital (Luminal)FDA Link
08/2016

Therapy/Procedure

31Therapeutics
05/2017 - 01/2002
7Drug Therapy (Chemotherapy)
05/2017 - 08/2006